
Legal
Latest News
Latest Videos

CME Content
More News

A discussion about the risks practices are going to face in the coming year

House approves landmark ‘Lower Costs, More Transparency Act.’

Comparison of UK, Australia, and US show similar mental illness rates but widely disparate gun violence rates

Law could change Medicare Physician Fee Schedule, affecting reimbursement to doctors.

Public-private partnerships will crumble, hurting drug innovation and eventually patients, Republicans say.

December meeting has two days of discussion planned.

About 23% are first-time enrollees

Kaiser Permanente program shows promise in improving feelings of well-being, building supportive departmental culture

The top news stories in primary care today.

Regulators ponder declaration about in vitro diagnostic products.

But harm is greater among Black patients, study finds

Value-based care to launch in eight states in July next year.


National Press Club learns about issues affecting a ‘health care system in crisis.’

Medicare Advantage could be a key part of potential transaction.

Communication and empathy are keys to overcoming technology-driven disasters

Private insurance covered over half of the visits, with Medicare, Medicaid, workers’ compensation, or self-pay accounting for almost 30%

Medical researchers have largely gone to white men to participate in studies. Health care leaders outline ways to cast a wider net, which will lead to better research and treatments for patients.

What does successful regulations for health care-specific AI models look like?

Physicians should not ignore the need for disability insurance.

Urology group leader explains why now is the time to reconsider USPSTF recommendations on screening in men.

Here’s what doctors and health care organizations need to know

Policy statement endorses diversifying supply chains, experimenting with government manufacture of generics

Finance Committee approved wide-ranging legislation this week.

AMA report finds that drop in opioid prescriptions and increased naloxone availability have had little impact










